IBEX 3519.940,40▼ -0,63%EuroStoxx 506451,41▼ -0,30%S&P 5007675,70▼ -0,02%€/$1,1652▼ -0,05%Brent87,45▲ +0,59%Bitcoin68.160▲ +0,53%

Breaking

Mortgage Signings in Málaga Reach Highest Levels Since 2010Manual transmission makes a comeback in luxury sports cars: Ferrari, BMW and Pagani launch new modelsAI Must Now Identify Itself: New Obligations in Spain from AugustMálaga, the third city in Southern Europe with the most potential for data centresMálaga Fair Sets Public Transport Record and Creates 1,400 JobsMijas approves the stabilisation of 380 temporary workers

Outlook Therapeutics

Latest Outlook Therapeutics news

2 articles

Primer plano de un frasco de colirio oftalmológico con un calendario borroso al fondo

Companies

Outlook Therapeutics: FDA to Decide on Eye Drug Lytenava on July 29

Outlook Therapeutics faces a pivotal July: shareholders vote on capital increase on the 16th and FDA decides on Lytenava on the 29th.

Beatriz Lorenzo Aguirre · 12 July 2026

Vial of medication on legal documents with a judge's gavel beside it, in a dimly lit boardroom

Companies

Outlook Therapeutics Faces a Decisive July Between the FDA and Capital Dilution

Outlook Therapeutics faces a crucial July: shareholder meeting for capital increase and FDA decision on its flagship drug. Shares rise 144% in 2026.

Beatriz Lorenzo Aguirre · 9 Jul 2026